Ana L Mora Selected Research

Interferon gamma Receptor

8/2010	Inhibition of NF-kappaB signaling reduces virus load and gammaherpesvirus-induced pulmonary fibrosis.
6/2007	Control of virus reactivation arrests pulmonary herpesvirus-induced fibrosis in IFN-gamma receptor-deficient mice.
10/2006	Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis.
11/2005	Lung infection with gamma-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ana L Mora Research Topics

Disease

13	Pulmonary Hypertension 01/2022 - 03/2013
12	Fibrosis (Cirrhosis) 03/2021 - 08/2005
9	Lung Injury 01/2020 - 02/2005
8	Hypoxia (Hypoxemia) 01/2022 - 03/2013
7	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2021 - 11/2005
7	Infections 01/2021 - 11/2005
6	Pulmonary Arterial Hypertension 01/2021 - 06/2014
6	Idiopathic Pulmonary Fibrosis 01/2020 - 01/2009
4	Vascular Remodeling 01/2022 - 02/2016
4	Lung Diseases (Lung Disease) 01/2019 - 12/2004
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 01/2013
3	Hypertrophy 01/2021 - 11/2017
3	Heart Failure 01/2020 - 02/2016
2	Virus Diseases (Viral Diseases) 01/2021 - 12/2004
2	Insulin Resistance 01/2020 - 02/2016
2	Hyperglycemia 01/2020 - 02/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 02/2016
2	Edema (Dropsy) 03/2013 - 07/2007
2	Pulmonary Edema 03/2013 - 02/2005
2	Bronchiolitis 03/2011 - 12/2008
2	Pneumonia (Pneumonitis) 07/2007 - 12/2004
1	Bradycardia 01/2021
1	Ventricular Fibrillation 01/2021
1	Atrial Remodeling 01/2021
1	Human Influenza (Influenza) 01/2021
1	Heart Arrest (Cardiac Arrest) 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Heart Diseases (Heart Disease) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2020
1	Glucose Intolerance 01/2020
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2018
1	Hemolysis 01/2018
1	Hypertension (High Blood Pressure) 12/2017
1	Starvation 12/2016
1	Hypersensitivity (Allergy) 12/2015

Drug/Important Bio-Agent (IBA)

9	Bleomycin (Blenoxane)FDA LinkGeneric 03/2021 - 08/2005
7	Semaxinib (SU5416)IBA 01/2022 - 02/2016
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2012
4	EndotoxinsIBA 03/2013 - 02/2005
4	CytokinesIBA 03/2013 - 02/2005
4	Interferon gamma ReceptorIBA 08/2010 - 11/2005
3	CollagenIBA 01/2020 - 11/2005
3	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 02/2016
3	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2017 - 10/2006
3	DNA (Deoxyribonucleic Acid)IBA 12/2017 - 01/2013
2	Tamoxifen FDA LinkGeneric 01/2022 - 12/2019
2	InterferonsIBA 01/2021 - 08/2010
2	Antiviral Agents (Antivirals)IBA 01/2021 - 06/2007
2	Sulfhydryl Compounds (Thiols)IBA 01/2021 - 01/2009
2	integrin-linked kinaseIBA 01/2020 - 10/2016
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2020 - 06/2014
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2020 - 02/2016
2	Leptin ReceptorsIBA 01/2020 - 02/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 06/2014
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 06/2014
2	PP242IBA 11/2017 - 12/2016
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2017 - 12/2016
2	Sirolimus (Rapamycin)FDA Link 11/2017 - 12/2016
2	NitritesIBA 02/2016 - 05/2013
2	NF-kappa B (NF-kB)IBA 08/2010 - 10/2005
2	AntioxidantsIBA 03/2010 - 01/2009
2	indium-bleomycinIBA 07/2009 - 01/2009
2	Transforming Growth Factor beta (TGF-beta)IBA 06/2007 - 11/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2005 - 02/2005
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 03/2021
1	Interferon Receptors (Interferon Receptor)IBA 01/2021
1	Dithiothreitol (Cleland's Reagent)IBA 01/2021
1	RelaxinIBA 01/2021
1	Interferon LambdaIBA 01/2021
1	maltoporinsIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2020
1	Fibronectins (Fibronectin)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	beraprostIBA 01/2020
1	SenotherapeuticsIBA 01/2020
1	treprostinil FDA Link 01/2020
1	Extracellular Matrix ProteinsIBA 01/2020
1	Cytochromes b5 (Cytochrome b5)IBA 12/2019
1	Oxidoreductases (Dehydrogenase)IBA 12/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Mitochondrial DNA (mtDNA)IBA 01/2019
1	BAY 54-6544IBA 01/2018
1	PTEN-induced putative kinaseIBA 01/2018
1	Soluble Guanylyl CyclaseIBA 01/2018
1	Mechanistic Target of Rapamycin Complex 2IBA 11/2017
1	Biological ProductsIBA 10/2017
1	LigandsIBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 02/2016
1	Sodium NitriteIBA 02/2016
1	AMP-Activated Protein KinasesIBA 02/2016
1	Sirtuin 3IBA 02/2016
1	NitratesIBA 02/2016
1	Protein Kinases (Protein Kinase)IBA 02/2016

Therapy/Procedure

8	Therapeutics 01/2020 - 06/2007
2	Lung Transplantation 03/2011 - 12/2008